several pharmacologic agents prevent the formation of mdf including membrane stabilizers ( e.g. , glucocorticoids ) , protease inhibitors ( e.g. , aprotinin ) , converting enzyme inhibitors ( e.g. , captopril ) , prostaglandins ( e.g. , pge1 and pgi2 ) , thromboxane synthetase inhibitors ( e.g. , imidazole , pta2 ) and local anesthetics ( e.g. , lidocaine ) .
C0033554
prostaglandins
C0002335
pge1